Countrywide
OTCMKTS:CYWDFCountrywide plc, together with its subsidiaries, provides residential estate agency and property services in the United Kingdom. It operates through Sales and Lettings, Financial Services, and Business to Business (B2B) segments. The company offers surveying services, including valuation panel management services, residential valuations, and surveys for mortgage lenders; provides corporate, emergency, commercial, and social relocation services; estate, leasehold and block management services; and sells residential, commercial, industrial, and agricultural properties, as well as land through public auction. It also provides integrated property services; conveyancing services, such as freehold and leasehold, remortgage, and separate legal representation; and residential property asset management services. In addition, the company is involved in the residential development and investment activities; and provision of single mortgage brokerage services, as well as home and personal insurance. It serves residential and commercial property markets. Countrywide plc was founded in 1986 and is headquartered in Milton Keynes, the United Kingdom. As of March 8, 2021, Countrywide plc operates as a subsidiary of Connells Limited.
Integra Resources
OTCMKTS:IRRZFIntegra Resources Corp. is a mineral resources company, which engages in the acquisition, exploration, and development of mineral properties. It holds interest in DeLamar Deposit and Florida Mountain Deposit projects. The company was founded on April 15, 1997 and is headquartered in Vancouver, Canada.
Nicox
OTCMKTS:NICXFNicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.
China Dili Group
OTCMKTS:RNHEFChina Dili Group, an investment holding company, engages in the operating, leasing, and managing agriculture wholesale markets in the People's Republic of China. It operates various wholesale markets in Harbin, Qiqihar, Mudanjiang, Shenyang, Shouguang, Guiyang, and Hangzhou. The company was formerly known as Renhe Commercial Holdings Company Limited and changed its name to China Dili Group in June 2019. China Dili Group was founded in 2002 and is based in Wanchai, Hong Kong.